Immunization of mice with myelin components results in experimental autoimmune encephalomyelitis (EAE), which is mediated by myelin-specific CD4+ T cells and anti-myelin antibodies. Tumor necrosis factor α (TNF-α) and lymphotoxin α (LT-α) are thought to be involved in the events leading to inflammatory demyelination in the central nervous system. To ascertain this hypothesis 129 × C57BL/6 mice with an inactivation of the tnf and lta genes (129 × C57BL/6−/−) and SJL/J mice derived from backcrosses of the above mentioned mutant mice (SJL−/−) were immunized with mouse spinal cord homogenate (MSCH) or proteolipid protein. Both 129 × C57BL/6−/− mice and SJL−/− mice developed EAE. In SJL−/− mice immunized with MSCH, a very severe form of EAE with weight loss, paralysis of all four limbs, and lethal outcome was observed. The histologic hallmark was an intense perivascular and parenchymal infiltration with predominantly CD4+ T cells and some CD8+ T cells associated with demyelination in both brain and spinal cord. These results indicate that TNF-α and LT-α are not essential for the development of EAE.
Skip Nav Destination
Article navigation
16 June 1997
Article Contents
Brief Definitive Report|
June 16 1997
Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis
Karl Frei,
Karl Frei
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Hans-Pietro Eugster,
Hans-Pietro Eugster
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Martin Bopst,
Martin Bopst
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Cris S. Constantinescu,
Cris S. Constantinescu
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Ehud Lavi,
Ehud Lavi
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Adriano Fontana
Adriano Fontana
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Search for other works by this author on:
Karl Frei
,
Hans-Pietro Eugster
,
Martin Bopst
,
Cris S. Constantinescu
,
Ehud Lavi
,
Adriano Fontana
From the *Department of Neurosurgery and ‡Section of Clinical Immunology, University Hospital Zürich, CH-8091 Zürich, Switzerland; §Swiss Federal Institute of Technology, Institute of Toxicology, CH-8603 Schwerzenbach, Switzerland; ‖Department of Neurology and ¶Department of Pathology, Division of Neuropathology, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Address correspondence to Dr. Karl Frei, Department of Neurosurgery, University Hospital Zürich, Rämistr. 100, CH-8091 Zürich, Switzerland, or to Dr. Adriano Fontana, Section of Clinical Immunology, University Hospital Zürich, Häldeliweg 4, CH-8044 Zürich, Switzerland.
Received:
February 12 1997
Revision Received:
April 14 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (12): 2177–2182.
Article history
Received:
February 12 1997
Revision Received:
April 14 1997
Citation
Karl Frei, Hans-Pietro Eugster, Martin Bopst, Cris S. Constantinescu, Ehud Lavi, Adriano Fontana; Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis. J Exp Med 16 June 1997; 185 (12): 2177–2182. doi: https://doi.org/10.1084/jem.185.12.2177
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement